See more : Winox Holdings Limited (6838.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Empower Clinics Inc. (EPWCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Empower Clinics Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Shandong Fengxiang Co., Ltd (9977.HK) Income Statement Analysis – Financial Results
- Standard Surfactants Limited (STDSFAC.BO) Income Statement Analysis – Financial Results
- Aryaman Capital Markets Limited (ARYACAPM.BO) Income Statement Analysis – Financial Results
- Semtech Corporation (SMTC) Income Statement Analysis – Financial Results
- Toyo Engineering Corporation (6330.T) Income Statement Analysis – Financial Results
Empower Clinics Inc. (EPWCF)
About Empower Clinics Inc.
Empower Clinics Inc., an integrated healthcare company, provides body and mind wellness services for patients through digital and telemedicine care, and medical diagnostics laboratories in the United States and Canada. The company operates a pipeline of 33 clinics in Alberta, British Columbia, and New Brunswick. It has a strategic alliance with SoLVBL Solutions Inc. to develop a program for data security in diagnostic testing. Empower Clinics Inc. is based in Vancouver, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.66M | 4.37M | 3.21M | 2.03M | 1.09M | 1.56M | 2.13K | 0.00 | 17.00K | 17.00K | 1.89M | 1.32M | 912.60K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 2.69M | 3.02M | 1.19M | 826.28K | 417.05K | 768.90K | 718.11 | 0.00 | 0.00 | 8.64M | 12.25M | 4.76M | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.97M | 1.35M | 2.02M | 1.21M | 674.34K | 792.35K | 1.42K | 0.00 | 17.00K | -8.62M | -10.36M | -3.44M | -434.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 42.22% | 30.87% | 62.81% | 59.33% | 61.79% | 50.75% | 66.36% | 0.00% | 100.00% | -50,729.41% | -548.54% | -259.71% | -47.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 962.73K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.20M | 4.60M | 3.74M | 3.80M | 4.50M | 113.00K | 268.00K | 349.00K | 93.00K | 2.29M | 2.31M | 4.89M | 1.97M | 1.37M | 247.64K | 90.64K | 68.05K | 17.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 652.13K | 751.51K | 1.03M | 313.87K | 306.80K | 171.81 | 60.35 | 0.00 | 0.00 | 0.00 | 0.00 | 401.00K | 0.00 | 4.57K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 6.75M | 5.35M | 4.77M | 4.12M | 4.81M | 113.00K | 268.00K | 349.00K | 93.00K | 2.29M | 2.31M | 5.29M | 1.97M | 1.38M | 247.64K | 90.64K | 68.05K | 17.45K | 34.47K | 73.49K | 140.33K | 178.59K | 264.37K | 43.79K |
| Other Expenses | 173.07K | 1.41M | 850.85K | 604.31K | 829.43K | 0.00 | 0.00 | 23.02K | 469.00K | 765.00K | 3.52M | 4.84M | 1.22K | 5.88K | 37.54K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 730.76K | 856.23K | 64.85K |
| Operating Expenses | 6.92M | 6.75M | 5.62M | 4.72M | 4.98M | 113.00K | 268.00K | 349.00K | 562.00K | 3.06M | 5.83M | 5.29M | 2.94M | 1.38M | 285.18K | 90.64K | 68.05K | 17.45K | 34.47K | 73.49K | 140.33K | 909.34K | 1.12M | 108.63K |
| Cost & Expenses | 9.62M | 9.78M | 6.81M | 5.55M | 5.40M | 113.00K | 268.00K | 349.00K | 562.00K | 3.06M | 5.83M | 10.05M | 2.94M | 1.38M | 285.18K | 90.64K | 68.05K | 17.45K | 34.47K | 73.49K | 140.33K | 909.34K | 1.12M | 108.63K |
| Interest Income | 911.23K | 185.41K | 7.57K | 4.98K | 0.00 | 6.00K | 0.00 | 0.00 | 0.00 | 3.03M | 2.48M | 43.00K | 398.00 | 0.00 | 40.06K | 0.00 | 31.87K | 360.00 | 0.00 | 1.29K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.55M | 185.41K | 539.41K | 355.05K | 367.90K | 0.00 | 0.00 | 0.00 | 0.00 | 30.00K | 745.00K | 109.00K | 0.00 | 0.00 | -285.18K | -90.64K | -35.40K | -18.75K | -64.09K | -341.81K | -137.40K | -893.77K | -1.11M | -108.63K |
| Depreciation & Amortization | 205.04K | 535.12K | 188.38K | 334.66K | 117.18K | 107.09K | 106.17K | 55.00K | 45.00K | 88.00K | 96.00K | 80.00K | 1.22K | 14.71K | 2.52K | 65.31K | 1.23K | 415.00 | 565.00 | 772.00 | 1.06K | 1.44K | 410.00 | 11.47K |
| EBITDA | -1.09M | -30.74M | -16.84M | -3.70M | -3.13M | -2.23M | -212.41K | -247.76K | 743.78K | -5.39M | -4.35M | -9.66M | -2.02M | -1.50M | -268.33K | 0.00 | -36.17K | -19.35K | -66.53K | -72.72K | -138.34K | -907.91K | -1.12M | -108.63K |
| EBITDA Ratio | -23.35% | -105.37% | -100.14% | -140.57% | -307.54% | -9.67% | -15,036.14% | 0.00% | -10,670.59% | 447.06% | -72.42% | -650.26% | -222.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -4.95M | -5.41M | -3.61M | -3.52M | -4.31M | -113.00K | -268.00K | -349.00K | 772.00K | -8.64M | -12.25M | -9.95M | -2.03M | -1.38M | -285.18K | -90.64K | -68.05K | -17.45K | -34.47K | -73.49K | -140.33K | -893.77K | -1.11M | -108.63K |
| Operating Income Ratio | -106.28% | -123.75% | -112.35% | -173.02% | -394.85% | -7.24% | -12,553.53% | 0.00% | 4,541.18% | -50,829.41% | -648.54% | -752.23% | -222.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 2.11M | -26.29M | -13.09M | -163.45K | 519.46K | -3.11M | -1.00K | 49.74K | 1.27M | -2.27M | -6.06M | -66.00K | 398.00 | 14.71K | 2.52K | 65.31K | 31.87K | -1.33K | -29.62K | -268.32K | 2.93K | 0.00 | 0.00 | 11.47K |
| Income Before Tax | -2.84M | -31.74M | -17.07M | -4.30M | -3.79M | -75.00K | -215.00K | -269.00K | 735.00K | -5.64M | -10.52M | -10.02M | -2.03M | -1.37M | -282.66K | -25.33K | -36.17K | -18.77K | -64.09K | -341.81K | -137.40K | -893.77K | -1.11M | -97.17K |
| Income Before Tax Ratio | -61.00% | -726.41% | -531.79% | -211.74% | -347.26% | -4.80% | -10,070.93% | 0.00% | 4,323.53% | -33,200.00% | -556.70% | -757.22% | -222.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 165.00 | 968.67K | 542.21K | 812.18K | -519.46K | -38.00K | -53.00K | -55.00K | 37.00K | 2.61M | 41.00K | 33.00K | 6.22K | 1.37M | 282.66K | 25.33K | 36.17K | 18.77K | 64.09K | 341.81K | 137.40K | 893.77K | 1.11M | 97.17K |
| Net Income | -2.83K | -32.70M | -17.61M | -5.11M | -3.79M | -75.00K | -215.00K | -269.00K | 735.00K | -5.64M | -8.55M | -10.05M | -2.03M | -1.37M | -282.66K | -25.33K | -36.17K | -18.77K | -64.09K | -341.81K | -137.40K | -893.77K | -1.11M | -97.17K |
| Net Income Ratio | -0.06% | -748.58% | -548.69% | -251.72% | -347.26% | -4.80% | -10,070.93% | 0.00% | 4,323.53% | -33,200.00% | -452.83% | -759.71% | -222.78% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.04 | -0.50 | -0.48 | -0.22 | -0.28 | -0.02 | -0.06 | -0.09 | 0.30 | -2.34 | -4.83 | -7.55 | -2.43 | -3.89 | -0.91 | -0.08 | -0.13 | -0.08 | -0.29 | -1.44 | -0.53 | -3.75 | -5.25 | -0.75 |
| EPS Diluted | -0.04 | -0.50 | -0.48 | -0.22 | -0.28 | -0.02 | -0.06 | -0.09 | 0.30 | -2.34 | -4.83 | -7.55 | -2.43 | -3.89 | -0.91 | -0.08 | -0.13 | -0.08 | -0.29 | -1.44 | -0.53 | -3.75 | -5.25 | -0.75 |
| Weighted Avg Shares Out | 70.21M | 65.60M | 36.47M | 23.46M | 13.33M | 3.42M | 3.42M | 3.09M | 2.43M | 2.41M | 1.77M | 1.33M | 835.20K | 352.20K | 309.33K | 309.33K | 268.96K | 221.33K | 221.33K | 237.88K | 261.33K | 238.34K | 210.76K | 129.55K |
| Weighted Avg Shares Out (Dil) | 70.21M | 65.60M | 36.47M | 23.46M | 13.33M | 3.42M | 3.42M | 3.09M | 2.43M | 2.41M | 1.77M | 1.33M | 835.20K | 352.20K | 309.33K | 309.33K | 268.96K | 221.33K | 221.33K | 237.88K | 261.33K | 238.34K | 210.76K | 129.55K |
Empower Clinics inks partnership deal to sell FDA-approved Atlas Medical products in US
Empower Clinics Inc announced that it has signed a partnership agreement with Alp Medtech AG, the authorized representative of European medical device company Atlas Medical Gmbh, to focus on the US market with immediate sales and marketing of US government-approved...
Empower Clinics announces closing of private placement, resignation of auditor and leadership transition at MediSure Canada
Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) told investors that it completed a non-brokered private placement of units at $0.05 each on December 13, raising aggregate gross proceeds of $842,500. In connection with the financing, the company said it issued 16,850,000 units.
Empower Clinics partners up with Specialty Networks of North America to address underserved communities in the US
Empower Clinics Inc, one of the largest operators of medical health and wellness centers in the US, revealed that it has signed a Letter of Intent (LOI) with Specialty Network of North America Inc (SNNA) to launch a healthcare network...
Empower Clinics sees Q3 revenue nearly triple thanks to COVID-19 testing,higher MediSure sales
Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has posted sharply higher revenue of $1,573,809 for the third quarter, a 288% jump from the previous year thanks to the launch of its COVID-19 testing clinics for cruise ship passengers in Vancouver, Canada, and...
Empower Clinics announces appointment of Eric Christian as new General Manager at Medisure Labs
Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has announced the appointment of Eric Christian as the new General Manager at Medisure Labs. The company noted that Christian has twenty years of experience as a proven leader and entrepreneur - with both business...
Empower Clinics announces proposed private placement, amendment of warrant terms and debt settlement
Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF) has announced its intention to complete a non-brokered private placement of secured convertible debenture units at a price of $1,000 per unit, for aggregate gross proceeds of $250,000, and of common share units at a...
Empower Clinics subsidiary inks MOU with Heart Wellness Cardiac Clinics to provide cardiology services
Empower Clinics Inc announced that its The Medi-Collective (TMC) subsidiary has signed a Memorandum of Understanding (MOU) to develop and launch a program for cardiology services and testing in partnership with Heart Wellness Cardiac Clinics (HWCC) and its subsidiary Holter...
Empower Clinics appoints US healthcare executive Alexis Wukich to its board
Empower Clinics Inc. (CSE:EPW, OTCQB:EPWCF), the integrated healthcare company, said it has appointed Alexis Wukich to its board of directors effective immediately. Wukich has 15 years of experience as an entrepreneur, lawyer, and talent management leader in the US medical industry.
Empower Clinics subsidiary MediSure Canada wins three-year contract from Correctional Service of Canada
Empower Clinics Inc said that Correctional Service of Canada (CSC) has awarded a three-year contract to its wholly-owned subsidiary MediSure Canada to provide diabetes testing solutions to inmates in federal prisons. The multi-year contract is worth an approximate total of...
Empower Clinics resumes trading with new Canadian stock symbol
Empower Clinics Inc. (CSE:CBDT, OTCQB:EPWCF) announced that its shares will resume trading on the Canadian Securities Exchange on or about November 8, 2022, after the British Columbia Securities Commission revoked its cease trade order. The company said that it will change...
Source: https://incomestatements.info
Category: Stock Reports